Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-07-06 18:11:29 UTC |
---|
Update Date | 2014-12-24 20:25:46 UTC |
---|
Accession Number | T3D2606 |
---|
Identification |
---|
Common Name | Dermonecrotic toxin (Pasteurella multocida) |
---|
Class | Protein |
---|
Description | Pasteurella multocida toxin (PMT) is the major pathogenic deteriment of Pasteurella multocida. Pasteurella multocida can cause a zoonotic infection in humans, which typically is a result of bites or scratches from domestic pets. (2) |
---|
Compound Type | - Amide
- Amine
- Bacterial Toxin
- Natural Compound
- Organic Compound
- Protein
|
---|
Protein Structure | |
---|
Synonyms | Synonym | Dermonecrotic toxin | DNT | Mitogenic toxin | PMT |
|
---|
Chemical Formula | Not Available |
---|
Average Molecular Mass | 146382.000 g/mol |
---|
CAS Registry Number | Not Available |
---|
Sequence | Not Available |
---|
Chemical Taxonomy |
---|
Description | Not Available |
---|
Kingdom | Organic Compounds |
---|
Super Class | Organic Acids |
---|
Class | Carboxylic Acids and Derivatives |
---|
Sub Class | Amino Acids, Peptides, and Analogues |
---|
Direct Parent | Peptides |
---|
Alternative Parents | Not Available |
---|
Substituents | Not Available |
---|
Molecular Framework | Not Available |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Liquid |
---|
Appearance | Clear solution. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | >10 mg/mL | LogP | Not Available |
|
---|
Predicted Properties | Not Available |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
|
---|
Toxicity Profile |
---|
Route of Exposure | Ingestion (3) ; inhalation (3) ; dermal (3) |
---|
Mechanism of Toxicity | Stimulation of several signalling pathways is induced by PMT. Most remarkable is a potent mitogenic effect. Phospholipase C-beta and the small GTPase Rho are activated due to stimulation of heterotrimeric G proteins of the Galpha(q), Galpha(i), and Galpha(12/13) families. (1) |
---|
Metabolism | Free toxin may be removed by opsonization via the reticuloendothelial system (primarily the liver and kidneys) or it may be degraded through cellular internalization via the lysosomes. Lysosomes are membrane-enclosed organelles that contain an array of digestive enzymes, including several proteases. |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Pasteurella multocida toxin (PMT) is the major pathogenic deteriment of Pasteurella multocida. (2) |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Pasteurella multocida toxin (PMT) is the major pathogenic deteriment of Pasteurella multocida. Pasteurella multocida can cause a zoonotic infection in humans, which typically is a result of bites or scratches from domestic pets. This causes an inflammatory reaction at the infection site (generally a diffuse localized cellulitis). It can also infect other locales, such as the respiratory tract. In more serious cases, a bacteremia can result, causing an osteomyelitis or endocarditis. The bacteria may also cross the blood-brain barrier and cause a meningitis. (2) |
---|
Symptoms | Pasteurella multocida can cause a zoonotic infection in humans, which causes an inflammatory reaction at the infection site (generally a diffuse localized cellulitis). It can also infect other locales, such as the respiratory tract. In more serious cases, a bacteremia can result, causing an osteomyelitis or endocarditis. The bacteria may also cross the blood-brain barrier and cause a meningitis. (2) |
---|
Treatment | This bacterium can be effectively treated with beta-lactam antibiotics, which inhibit cell wall synthesis. It can also be treated with fluoroquinolones or tetracyclines; fluoroquinolones inhibit bacterial DNA synthesis and tetracyclines interfere with protein synthesis by binding to the bacterial 30S ribosomal subunit. Because P. multocida is most often acquired as a result of a bite (notably dog), infections are frequently polymicrobial and involve anaerobic bacteria. As a result, amoxicillin-clavulanate (a beta-lactamase inhibitor/penicillin combination) is seen as the treatment of choice. (2) |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
PubChem Compound ID | Not Available |
---|
ChEMBL ID | Not Available |
---|
ChemSpider ID | Not Available |
---|
KEGG ID | Not Available |
---|
UniProt ID | P17452 |
---|
OMIM ID | |
---|
ChEBI ID | Not Available |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Dermonecrotic toxin |
---|
PDB ID | 2EBF |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | T3D2606.pdf |
---|
General References | - Orth JH, Preuss I, Fester I, Schlosser A, Wilson BA, Aktories K: Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7179-84. doi: 10.1073/pnas.0900160106. Epub 2009 Apr 15. [19369209 ]
- Wikipedia. Pasteurella multocida. Last Updated 5 August 2009. [Link]
- Wikipedia. Bacterial toxin. Last Updated 27 February 2009. [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|